This event has been postponed, new dates to follow. Looking forward to having Keith Loo from Skinopathy speak at our "Canada's MedTech Research Event" his educational talk: "AI in MedTech: Reshaping Dermatology & Oncology Healthcare" Learning Objectives: 1. Review the concept and development stage of Skinopathy-an AI Medtech Diagnostic Device including implementing practical use in real world settings 2. Discuss the regulatory approval & commercialization path 3. Discuss addressing the dermatology gap of assessing & diagnosis of skin disease in Skin of Colour (SOC) Learning objective three is very interesting as a previous study found 47% of dermatologists felt training was inadequate to diagnose disease in skin of colour patients Kim McDonald-Taylor Jaspreet K Grewal, MBA Adrijana D'Silva Alex Karabanow 🌍 🍁 🇨🇭 Angelina Brathwaite Robert Tam Sharareh Hosseinzadeh Mo Amin Jen Belcher Nate Stepner David Warwick Frank Shannon #medtech #devices #dermatology #oncology #clinicaltrials #clinicalresearch #medicaldevices #healthcanada #AI #Canada #diagnostics
Sabrina R.’s Post
More Relevant Posts
-
[Inno 360°] Side Onco Skin is a tool for oncology and dermatology professionals worldwide, developed in partnership with Eau Thermale Avène and specialized onco-dermatologists Pr.Caroline Knebelman-Robert (Gustave Roussy institute) and Dr.Vincent SIBAUD (IUCT-Oncopole) 🔍 Managing dermatological toxicities associated with anti-cancer treatments is paramount for oncologists and dermatologists. This is why the Side Onco Skin directory was created: to assist healthcare professionals in identifying and treating such side effects. This unique platform allows: 👉 Rapid identification and explanation of conditions for patients through pictures. 👉 A user-friendly interface for quick access to information on a wide range of symptoms. 👉 Regular contributions from leading experts, such as Prof. Vincent Sibaud. 👉 Interactive tests to track knowledge progression in an engaging and educational way. Another innovative advance in the field of #OncoDermatology. #PierreFabre #NewWaysToCare #Oncology #Dermatology #PatientCare #MedicalApp #Avene
To view or add a comment, sign in
-
Which medical specialties do you think are most researched? M3’s panel team recently shared a blog highlighting the top six specialties that are currently in high demand for paid surveys. Topping the list are: 1. Oncology and haematology 2. Cardiology 3. Dermatology Find out which other specialties made the top spots and what impacts the availability of paid medical surveys > https://hubs.ly/Q02sGJCf0 #Marketresearch #Healthcare #MedicalSpecialties #Paidsurveys #Oncology #Haematology #Cardiology #Dermatology
To view or add a comment, sign in
-
Exciting News! 🚀 Lynx is expanding our data offerings in a new way, adding Dermatology as one of our key specialty areas. Unstructured notes and reports provides life sciences with a robust picture of dermatologic disease activity, location of disease, %BSA impacted, and many other clinical outcomes measures. Key diseases include (but are not limited to): dermatitis, vitiligo, psoriasis, skin malignancies, HS, and alopecia. If you are working in the inflammation and immunology space and have not yet heard of Lynx.MD, now is the time for an intro before you fall behind. Dermatology ✅ Gastroenterology ✅ ENT / Allergy / Asthma ✅
📢🧑⚕️ We’re proud to share that Lynx.MD has partnered with Schweiger Dermatology Group to advance dermatology research using real-world data. This alliance will establish a unique RWD repository, empowering researchers, pharmaceutical companies 💊, and medical practitioners 🩺 with rich, anonymized patient data. Our collaboration will harness AI 🤖 and NLP to drive innovations in treating conditions like acne, eczema, psoriasis, rosacea, and skin cancer. Through data, we are paving the way for better treatments and improved patient outcomes. Read now: https://lnkd.in/gPSC2RsJ #RWD #Immunology #Research #Dermatology #AI #Data
To view or add a comment, sign in
-
Anyone in #digitalhealth can tell you the challenge it is to reach the starting line (i.e. vendor selection, first deployment, start date of a trial) with a world-class sponsor organization like AbbVie who's entrusted you with digital biomarker capture via wearable sensor to support their clinical development outcomes and goals. Makes it all the more thrilling when the results achieved at the end match the objective from the start. Published last month in the Journal of the American Academy of Dermatology (JAAD), the abstract below presents results from the PRIMMA study where our ADAM sensor demonstrated sensitivity to scratch measurements after 4 weeks of treatment in moderate-to-severe #psoriasis patients. cc: Sandy Goss and Liuqing (Jasmine) Yang #digitalhealthtechnologies #wearablesensors #immunology #dermatology #nocturnalscratch #objectivedata #clinicaltrials #atopicdermatitis #pruritus #clinicaldevelopment #pharma https://lnkd.in/gYyggTX5
52098 Digital Monitoring of Nocturnal Scratch in Psoriasis Patients Treated with Risankizumab: Results from the PRIMMA Study Digital Arm
jaad.org
To view or add a comment, sign in
-
Transcriptomics: A "Game Changer" in Managing Severe Inflammatory Skin Diseases We are pleased to announce a recent article co-authored by Emmanuel Contassot from the Navarini Lab at the Department of Biomedicine in Sciences Advances (Science Magazine). In this publication, their team – in collaboration with Dr. Antonios Kolios from the Dermatology Department at Universitätsspital Zürich – analyzed transcriptomic data from Pityriasis rubra pilaris (PRP) patients. PRP is a severe inflammatory skin condition that significantly reduces quality of life. Their precision medicine approach revealed IL-1β as a key driver in PRP, leading to successful treatment of three therapy-resistant patients using IL-1β antagonists, anakinra and canakinumab. All patients showed rapid and significant improvements, highlighting how transcriptomics can be a “game changer” in managing severe inflammatory skin diseases. Congratulations to everyone involved in these groundbreaking findings. Publication Link: https://lnkd.in/e8iCeDXH #PrecisionMedicine #Dermatology #TranslationalResearch #Collaboration #Inflammation #PRP
To view or add a comment, sign in
-
Our Dermatology R&D clients are excited about the powerful synergy of histology, IHC/IF, and image analysis we deliver. This trio is essential for uncovering detailed cellular insights into drug target expression and understanding the effects of drug responses. Our Quantitative Digital Pathology services provide crucial insights, helping our clients make well-informed decisions in various therapeutic areas such as Dermatology, NASH, Fibrosis, Immuno-Oncology, and more. Find out how we can enhance your decision-making: https://lnkd.in/egYrENdt 🤝 —— #dermatology #digitalpathology #computationalpathology #drugdevelopment #histopathology #biomedicalresearch #histology #quantitativepathology #dermatologyresearch #tissuediagnostic
To view or add a comment, sign in
-
🎉 Exciting Research Publication! 🎉 I'm thrilled to share that my latest research paper has been published in the #D1 journal [Scientific Reports/Nature]. This work explores the efficacy and safety of topical glycopyrronium bromide in treating primary axillary hyperhidrosis, a chronic condition characterized by excessive sweating. The key findings from this systematic review and meta-analysis include: 📌 Topical glycopyrronium bromide significantly increased responders on the Hyperhidrosis Disease Severity Scale and Axillary Sweating Daily Diary compared to placebo. 📌 Patients in the glycopyrronium bromide group also showed significant improvements in their Dermatology Life Quality Index. 📌 While adverse events like dry mouth were observed, serious side effects were not significant, making glycopyrronium bromide a promising treatment option. This research highlights an important therapeutic approach to improving the quality of life for those affected by primary hyperhidrosis. I'm grateful to the team of collaborators who contributed to this impactful work. You can access the full paper here: [https://lnkd.in/d2srUaHJ] #Research #Publication #ScientificReports #Hyperhidrosis #Dermatology #MedicalResearch
To view or add a comment, sign in
-
🔥 In-Depth Insight from EADV 2024! Prof. Dr. Jan Gutermuth from the University Hospital Brussels shares his insights on: 1️⃣ Whether patients with BP should undergo routine cancer screening. 2️⃣ The current and future need for in-patient dermatology beds in light of new treatments and surgical advancements. Discover these updates.👇 For all EADV 2024 videos, find the link in the comments! #MediMix #EADV2024 #Dermatology #MedicalResearch #DermatologyAdvancements
To view or add a comment, sign in
-
🧬#MolecularDiagnostics of inflammatory skin diseases in difficult to distinguish cases enables evaluation of tissue samples #BeyondTheSurface. DNA and RNA based tests will improve precision in diagnostics, unfold the full potential of specific therapeutics and thus improve patient care. You want to join our journey of #MovingDiagnosticFrontiers in dermatology? Stay fully informed about the latest advancements in molecular diagnostics in dermatology by subscribing to our forthcoming newsletter. Receive updates on our newest publications, events, and much more: https://lnkd.in/esGZt8MZ #Dermatology #Psoriasis #Eczema #Newsletter #SubscribeNow
Molecular Diagnostics in Dermatology
To view or add a comment, sign in
-
Would you like to know more about the common clinical characteristics of major dermatological disorders? Join Global Medical Advisor, Alejandro Castillo Mondragón, and Business Development Manager, Sofie Arpe, at the EADV Congress in Amsterdam, 25-28 September 2024, where they will be happy to discuss Blueskin CRO's accepted abstract: Baseline characteristics of participants from a prospective cohort study in four different dermatological disorders. The abstract describes the baseline characteristics of our ongoing cohort study following patients with Atopic Dermatitis, Alopecia Areata, Psoriasis and Vitiligo in Denmark. In this observational study we are collecting real-life data on disease progression, treatment efficacy and patient outcomes. Reach out to secure a meeting - we look forward to engaging in insightful discussions on the latest research and innovations in dermatology. See you there! #EADVCongress #ContractResearch #Dermatology #partofSanosGroup
To view or add a comment, sign in
Co-Founder & CEO @ Skinopathy | Revolutionizing Dermatology with Advanced Data & AI
9moLooking forward to this!